177O Lenvatinib plus pembrolizumab versus treatment of physician’s choice in patients with previously treated advanced endometrial cancer: Study 309/KEYNOTE-775 Asian subgroup
Autor: | K. Yonemori, K. Fujiwara, K. Hasegawa, M. Yunokawa, K. Ushijima, S. Suzuki, A. Shikama, S. Minobe, T. Usami, J-W. Kim, B-G. Kim, P-H. Wang, T-C. Chang, K. Yamamoto, S. Han, J. McKenzie, G. Barresi, T. Miura, V. Makker, Y.M. Kim |
---|---|
Rok vydání: | 2022 |
Předmět: | |
Zdroj: | Annals of Oncology. 33:S1504-S1505 |
ISSN: | 0923-7534 |
Databáze: | OpenAIRE |
Externí odkaz: |